(Reuters) – U.S. health regulators on Friday approved expanding the heart benefit claims Amarin Corp can make in promoting its drug Vascepa to include reducing the risk of heart attacks and strokes in high-risk patients, opening a multibillion-dollar market op... More »
(Reuters Health) – No one can say if it’s the walks or the unconditional love, but there’s something about owning a dog that goes hand in hand with better heart health, suggests a study in eastern Europe. Researchers examined more than 1,700 adults in the Czec... More »
(Reuters Health) – Where heart attack survivors live in the U.S. may affect their chances of getting the best medication to prevent a second attack, a new study suggests. Researchers found that New Englanders were most likely to get the right therapy after a h... More »
GV, Alphabet Inc’s venture capital arm, led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases. Gene editing therapies are seen to have huge scope in treatin... More »
(Reuters Health – In a small pilot study that screened 45 Ohio middle school students for cardiovascular risk factors, a third of the children had abnormal levels of cholesterol or blood sugar, and two kids were found to have undiagnosed diabetes. Guidelines r... More »
(Reuters Health) – After a raft of studies reassuring consumers that eggs are OK to eat, a new report associates an increasing risk of heart disease with the increasing consumption of eggs. The report, combining data from six earlier studies, found a 6 percent... More »
(Reuters Health) – Diabetic patients who take statins to treat high cholesterol may get an added benefit: a lower risk of damage to the retina, a new study suggests. Researchers found that diabetic patients taking statins were 14 percent less likely to develop... More »
(Reuters Health) – Adult survivors of childhood cancer have a greater risk of heart disease and develop risk factors like high blood pressure and elevated cholesterol earlier in life compared to the general population, a German study suggests. Researchers stud... More »
(Reuters Health) – People living in the U.S. but born elsewhere may have lower risk for heart disease and stroke than their native-born neighbors, suggests a new study. Foreign-born residents had a range of risks, however. Women from Europe and men from Africa... More »
Aegerion Pharmaceuticals Inc will plead guilty to two misdemeanors and pay $40.1 million to resolve investigations into its marketing and sales of an expensive cholesterol drug, U.S. authorities said on Friday. More »
By Lisa Rapaport(Reuters Health) – Hailing from the so-called stroke belt, a band of southern U.S. states with high stroke mortality rates, is associ More »
By Will Boggs MD(Reuters Health) – An eight-week mindfulness-based stress reduction (MBSR) program not only reduces stress, but could also lower bloo More »
By Carolyn Crist(Reuters Health) – Middle aged adults who do even a small amount of regular strength training exercise may be lowering their risk of More »
By Will Boggs MD(Reuters Health) – Meeting some or all of the American Heart Association’s seven ideal cardiovascular health goals is associated with More »
By Shereen Lehman(Reuters Health) – If a parent or sibling has cirrhosis due to non-alcoholic fatty liver disease, a person’s odds of having liver sc More »
By Andrew M. SeamanHeart health in the U.S. has generally improved since the start of the 21st century, but not for adults living in poverty, a new More »
By Lisa Rapaport(Reuters Health) – Many patients with peripheral artery disease, a common cause of chronic disability and mobility limitations in the More »
Gridlock traffic is pictured on highway 395 as people evacuate Washington after an earthquake August 23, 2011. REUTERS/Jason Reed By Lisa Rapaport(Reuters Health) – People who live near sources of heavy traffic exhaust may be at higher risk of heart disease be... More »
By Gene Emery(Reuters Health) – – For overweight people with heart disease, trying and failing to lose weight may be more dangerous than not losing w More »
By Lisa Rapaport(Reuters Health) – It may be tempting to latch on to the latest diet fad like juicing or going gluten-free to lose weight or achieve More »
By Carolyn CristEven without high blood pressure or other signs of illness, obese adults have a much higher risk of developing heart disease than nor More »
An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo Amgen Inc (AMGN.O) sells its cholesterol-lowering drug Repatha at a discount of about 30 percent to its U.S. list price of $1... More »
FILE PHOTO – An Amgen sign is seen at the company’s office in South San Francisco, California, U.S. on October 21, 2013. REUTERS/Robert Galbraith/File Photo Amgen Inc’s (AMGN.O) $14,000 cholesterol drug Repatha cut the risk of heart attack and stroke by over 2... More »
Data that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting this week as the future of the only rival drug rests with the courts in an ongoing patent dispute. More »
By Will Boggs MD(Reuters Health) – Herbal medications offer few benefits and many risks for people with heart disease, according to a recent review. More »
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo A U.S. appeals court on Wednesday stayed an order that would have blocked Regeneron Pharmaceuticals Inc and... More »
An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith Regeneron Pharmaceuticals Chief Executive Len Schleifer on Monday ripped into Amgen Inc for its insistence on blocking sales of a rival ... More »
By Lisa Rapaport(Reuters Health) – Traditional treadmill tests used to estimate heart disease risk might not provide accurate results for women, a re More »
By Madeline Kennedy (Story refiles from August 3rd instance to add new paragraph 5) By Madeline Kennedy More »
PARIS French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called “bad cholesterol,” or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia. The dr... More »
